Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma therapies, today announced positive topline results from the investigational Phase 3 MajesTEC-3 study. The study evaluates the ...
54m
New Listings Creep Up As Would-Be Homebuyers Back Off, Haunted By High Prices and Economic Unease
New listings of U.S. homes for sale rose 4.1% year over year during the four weeks ending October 12, the biggest increase in over four months, according to a new report from Redfin, the real estate ...
Shaving is not cosmetic; it is daily doctrine that preserves your skin and your gas mask seal, and a single blade used with ...
A new study finds that CPD enzyme deficiency leads to hereditary deafness, but boosting nitric oxide with arginine could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback